Arvas M - Search Results

1

Predicting haemoglobin deferral using machine learning models: Can we use the same prediction model across countries?

Meulenbeld A, Toivonen J, Vinkenoog M, Brits T, Swanevelder R, de Clippel D, Compernolle V, Karki S, Welvaert M, van den Hurk K, van Rosmalen J, Lesaffre E, Janssen M, Arvas M. Meulenbeld A, et al. Among authors: arvas m. Vox Sang. 2024 Apr 18. doi: 10.1111/vox.13643. Online ahead of print. Vox Sang. 2024. PMID: 38637123

2

Synthesis of novel coumarin-triazole hybrids and first evaluation of the 4-phenyl substituted hybrid loaded PLGA nanoparticles delivery system to the anticancer activity.

Arvas B, Ucar B, Acar T, Varlı HS, Arvas MB, Aydogan F, Yolacan C. Arvas B, et al. Among authors: arvas mb. Nanotechnology. 2024 Apr 18. doi: 10.1088/1361-6528/ad403e. Online ahead of print. Nanotechnology. 2024. PMID: 38636487

3

Iron status in Dutch and Finnish blood donor and general populations: A cross-cohort comparison study.

Karregat JHM, Ekroos S, Castrén J, Arvas M, van den Hurk K. Karregat JHM, et al. Among authors: arvas m. Vox Sang. 2024 Apr 15. doi: 10.1111/vox.13639. Online ahead of print. Vox Sang. 2024. PMID: 38622934

4

Comprehensive Inherited Risk Estimation for Risk-Based Breast Cancer Screening in Women.

Mars N, Kerminen S, Tamlander M, Pirinen M, Jakkula E, Aaltonen K, Meretoja T, Heinävaara S, Widén E, Ripatti S; FinnGen. Mars N, et al. J Clin Oncol. 2024 May 1;42(13):1477-1487. doi: 10.1200/JCO.23.00295. Epub 2024 Feb 29. J Clin Oncol. 2024. PMID: 38422475

5

NAD⁺ Precursors Reverse Experimental Diabetic Neuropathy in Mice.

Chandrasekaran K, Najimi N, Sagi AR, Yarlagadda S, Salimian M, Arvas MI, Hedayat AF, Kevas Y, Kadakia A, Kristian T, Russell JW. Chandrasekaran K, et al. Among authors: arvas mi. Int J Mol Sci. 2024 Jan 16;25(2):1102. doi: 10.3390/ijms25021102. Int J Mol Sci. 2024. PMID: 38256175 Free PMC article.

6

High-Resolution Genotyping of Formalin-Fixed Tissue Accurately Estimates Polygenic Risk Scores in Human Diseases.

Youssef O, Loukola A, Zidi-Mouaffak YHS, Tamlander M, Ruotsalainen S, Kilpeläinen E, Mars N, Ripatti S; FinnGen; Palotie A, Donner K, Carpén O. Youssef O, et al. Lab Invest. 2024 Apr;104(4):100325. doi: 10.1016/j.labinv.2024.100325. Epub 2024 Jan 14. Lab Invest. 2024. PMID: 38220043 Free article.

7

Sex-specific genetic risks for adverse outcomes after coronary revascularization procedures.

Nurkkala JM, Aittokallio J; FinnGen; Kauko A, Niiranen T. Nurkkala JM, et al. Interdiscip Cardiovasc Thorac Surg. 2024 Jan 2;38(1):ivae006. doi: 10.1093/icvts/ivae006. Interdiscip Cardiovasc Thorac Surg. 2024. PMID: 38216540 Free PMC article.

8

Blood donor biobank as a resource in personalised biomedical genetic research.

Clancy J, Ritari J, Vaittinen E, Arvas M, Tammi S; FinnGen; Koskela S, Partanen J. Clancy J, et al. Among authors: arvas m. Eur J Hum Genet. 2024 Jan 12. doi: 10.1038/s41431-023-01528-0. Online ahead of print. Eur J Hum Genet. 2024. PMID: 38212662

9

NTHL1 is a recessive cancer susceptibility gene.

Nurmi AK, Pelttari LM, Kiiski JI, Khan S, Nurmikolu M, Suvanto M, Aho N, Tasmuth T, Kalso E, Schleutker J, Kallioniemi A, Heikkilä P; FinnGen; Aittomäki K, Blomqvist C, Nevanlinna H. Nurmi AK, et al. Sci Rep. 2023 Nov 30;13(1):21127. doi: 10.1038/s41598-023-47441-w. Sci Rep. 2023. PMID: 38036545 Free PMC article.

10

The value of genetic data from 665,460 individuals in managing iron deficiency anaemia and suitability to donate blood.

Toivonen J, Allara E; FinnGen; Castrén J, di Angelantonio E, Arvas M. Toivonen J, et al. Among authors: arvas m. Vox Sang. 2024 Jan;119(1):34-42. doi: 10.1111/vox.13564. Epub 2023 Nov 28. Vox Sang. 2024. PMID: 38018286

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

157 results

Search Page